Accelerate Clinical Trials with Our Unified eClinical Platform
Ten purpose-built modules — from EDC and RTSM to RBQM and real-time analytics — designed for regulatory compliance, operational efficiency, and faster time to database lock.
Ten Modules. One Unified Ecosystem.
Every module is purpose-built for clinical research, fully validated, and designed to work together or independently within your existing technology stack.
EDC
Electronic Data Capture
Streamline study builds with CDISC-aligned CRF design, intelligent edit checks, and automated query management for faster database lock.
Learn MoreRTSM / IRT
Randomisation & Trial Supply
Configurable randomisation algorithms, real-time drug supply forecasting, and blinding management with complete audit trails.
Learn MoreCTMS
Clinical Trial Management
Centralised site management, milestone tracking, financial oversight, and operational dashboards for end-to-end study execution.
Learn MoreePRO / eCOA
Patient Reported Outcomes
Validated instruments across mobile, tablet, and web with smart reminders, offline capability, and multi-language support.
Learn MoreeConsent
Digital Informed Consent
Multimedia-rich consent flows with comprehension checks, remote e-signatures, version control, and IRB/EC integration.
Learn MoreDocuVault eTMF
Electronic Trial Master File
DIA reference model structure, automated filing, quality review workflows, completeness dashboards, and inspection-ready exports.
Learn MorerSDV
Remote Source Verification
Secure remote access to source documents, structured verification workflows, and seamless EDC integration for decentralised monitoring.
Learn MoreeClinical Analytics
Intelligence & Reporting
Cross-module dashboards with configurable KRIs, predictive modelling, risk signal detection, and automated regulatory reporting.
Learn MoreAdjudication
Endpoint Adjudication
Committee management, blinded case dossier assembly, consensus voting workflows, and comprehensive adjudication analytics.
Learn MoreRBQM
Risk-Based Quality Management
Centralised monitoring, KRI dashboards, quality tolerance limits, risk signal detection, and ICH E6(R2)/R3 aligned oversight.
Learn MoreStrategic Expertise Across the Clinical Lifecycle
Beyond technology, our domain experts bring decades of hands-on experience in pharmaceutical consulting, regulatory strategy, and clinical operations.
- Regulatory strategy and global submission planning
- Clinical data management and CDISC standards
- Biostatistics and statistical analysis plans
- SAS programming for TLFs and SDTM/ADaM
- Quality assurance and GxP compliance audits
- Pharmacovigilance and safety reporting
- Protocol development and medical writing
Partnering Across the Life Sciences Ecosystem
Pharma & Biotech
Supporting sponsors from early phase through post-marketing with end-to-end clinical technology and consulting services.
Contract Research Organisations
Scalable, multi-sponsor platform infrastructure with rapid study configuration and enterprise-grade SLA support.
Clinical Sites & Hospitals
Intuitive tools that simplify site workflows, reduce administrative burden, and accelerate patient enrolment timelines.
Built for the Demands of Modern Clinical Research
Unified Platform
All nine modules share a common data layer, eliminating silos and enabling cross-functional visibility.
Validated & Compliant
Full IQ/OQ/PQ validation documentation with electronic signatures and comprehensive audit trails.
Cloud-Native Architecture
Secure, scalable multi-tenant infrastructure with 99.8% uptime and SOC 2 Type II certification.
Rapid Deployment
Go live within weeks, not months. Pre-configured templates and guided setup reduce time to first patient.
Latest Regulatory News & Insights
Stay informed with the latest guidance, approvals, and regulatory developments from global health authorities shaping the future of clinical research.
Efforts to eliminate hepatitis delivers gains but more action needed to meet 2030 targets
Global efforts to combat viral hepatitis are delivering measurable progress in reducing infections and deaths, but the disease remains a major global health ...
Read Full ArticleMHRA delivers its targets to increase access to medicines and reinforce UK position as a global destination for life sciences
The MHRA continues to speed up access to medicines for patients, increase efficiency of regulation and help to attract innovation and investment in the UK’...
Read Full ArticlePracticing today for tomorrow’s emergencies – WHO convenes countries and partners to simulate response to major disease outbreak
The World Health Organization (WHO) wrapped up Exercise Polaris II, a 2-day high-level simulation exercise, based around an outbreak of a fictional new bacte...
Read Full ArticleLaunch of clinical trial reforms
Patients in the UK to get access to new treatments faster and still safely under new clinical trial regulations coming into force on 28 April 2026.
Read Full ArticleWHO prequalifies first-ever malaria treatment for newborns and infants, adds new diagnostic tests
Ahead of World Malaria Day on 25 April, the World Health Organization (WHO) has announced a significant step forward in the fight against malaria with the pr...
Read Full ArticleAutomatically updated from official regulatory RSS feeds
Ready to Transform Your Clinical Trials?
Discover how our integrated platform and consulting expertise can streamline your operations and accelerate your path to regulatory approval.